Envista Holdings to Present at Jefferies London Healthcare Conference

Trending News 🌥️

ENVISTA HOLDINGS ($NYSE:NVST) is a leading provider of dental products and services. The company will be participating in the Jefferies London Healthcare Conference. This conference is a leading event for healthcare professionals.

Market Price

This will be the company’s first major presentation since going public, and investors are hopeful that Envista will be able to build on the positive momentum it has generated so far. So far, news about Envista has been mostly positive. The company’s IPO was well-received, and its stock has been steadily climbing since then.

However, on Wednesday, Envista’s stock took a slight dip, opening at $34.1 and closing at $33.5. This represents a 2.0% decline from the previous day’s closing price of $34.2. Despite this small setback, investors remain confident in Envista’s potential. The company is still in its early stages, and there is a lot of room for growth. Envista’s management team is experienced and has a proven track record of success. With this in mind, the future looks bright for Envista Holdings.

VI Analysis

Company’s fundamentals reflect its long term potential, and the VI app makes it easy to see how ENVISTA HOLDINGS stacks up. The VI Star Chart shows that ENVISTA HOLDINGS is classified as an “elephant,” a type of company that is rich in assets after deducting off liabilities. This makes it attractive to investors who are looking for a company with a strong balance sheet.

However, ENVISTA HOLDINGS is only medium-sized in terms of profitability and weak in terms of dividend growth. Nevertheless, the company has a high health score of 8/10, indicating that it is capable of safely riding out any crisis without the risk of bankruptcy.

VI Peers

Its main competitors are Medikit Co Ltd, Nihon Kohden Corp, and Fukuda Denshi Co Ltd. Envista has a strong market presence in the US, Europe, and Asia Pacific.

– Medikit Co Ltd ($TSE:7749)

As of 2022, Medikit Co Ltd has a market cap of 41.17B and a Return on Equity of 6.14%. The company produces and sells medical equipment and supplies. It offers a wide range of products, including medical devices, pharmaceuticals, and over-the-counter drugs. Medikit also provides services, such as medical examinations and consultations.

– Nihon Kohden Corp ($TSE:6849)

Nihon Kohden is a Japanese manufacturer of medical equipment, with a particular focus on patient monitoring systems. The company has a market cap of 278.79B as of 2022 and a return on equity of 13.19%. Nihon Kohden has a long history, dating back to 1951, and has been a leading player in the medical equipment industry for many years. The company’s products are used in hospitals and clinics around the world, and it has a strong reputation for quality and reliability.

– Fukuda Denshi Co Ltd ($TSE:6960)

Fukuda Denshi Co Ltd is a Japanese company that manufactures and sells medical equipment. The company has a market cap of 138.83B as of 2022 and a Return on Equity of 9.95%. Fukuda Denshi is a leading manufacturer of medical equipment and supplies, and its products are used in hospitals and clinics around the world. The company’s products include medical imaging devices, patient monitors, and medical electronics.

Summary

Envista Holdings is a global medical technology company that offers a comprehensive portfolio of products, services and solutions to meet the needs of dental and other medical professionals. The company has a strong focus on innovation and is constantly introducing new products and solutions to the market. Investors considering an investment in Envista Holdings should be aware that the company has a strong track record of delivering shareholder value.

Envista Holdings has a history of consistently growing its earnings and revenue, and it has outperformed the broad market indices over the long term. The company has a strong balance sheet and is well-positioned to continue delivering strong financial results in the future.